Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bashir Endovascular Catheter for Acute Pulmonary Embolism
NCT03927508Phase 1Completed
- Sponsor
- Thrombolex
- Start
- Mar 2019
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Thrombolex. Primary endpoint: Number of Participants With Major Bleeding Events at 72 hours. Started Mar 2019; status: completed.
Beyond the preview
Go deeper on NCT03927508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03927508.